These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 21506882)
1. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin. Bandarkar FS; Vavia PR Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882 [TBL] [Abstract][Full Text] [Related]
2. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies. Shende PK; Gaud RS; Bakal R; Patil D Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091 [TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Desai C; Prabhakar B Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555 [TBL] [Abstract][Full Text] [Related]
4. Utilization of spray drying technique for improvement of dissolution and anti-inflammatory effect of Meloxicam. Shazly G; Badran M; Zoheir K; Alomrani A Pak J Pharm Sci; 2015 Jan; 28(1):103-11. PubMed ID: 25553688 [TBL] [Abstract][Full Text] [Related]
5. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Jug M; Maestrelli F; Bragagni M; Mura P J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541 [TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
7. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability. Radia O; Rogalska E; Moulay-Hassane G Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700 [TBL] [Abstract][Full Text] [Related]
10. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex. Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590 [TBL] [Abstract][Full Text] [Related]
11. Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® Dispersing. Hughey JR; Keen JM; Brough C; Saeger S; McGinity JW Int J Pharm; 2011 Oct; 419(1-2):222-30. PubMed ID: 21864663 [TBL] [Abstract][Full Text] [Related]
12. Development of meloxicam formulations utilizing ternary complexation for solubility enhancement. Awasthi SS; Kumar TG; Manisha P; Preeti Y; Kumar SS Pak J Pharm Sci; 2011 Oct; 24(4):533-8. PubMed ID: 21959817 [TBL] [Abstract][Full Text] [Related]
13. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. Ghareeb MM; Abdulrasool AA; Hussein AA; Noordin MI AAPS PharmSciTech; 2009; 10(4):1206-15. PubMed ID: 19862626 [TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins. Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111 [TBL] [Abstract][Full Text] [Related]
15. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique. El-Maradny HA; Mortada SA; Kamel OA; Hikal AH Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579 [TBL] [Abstract][Full Text] [Related]
17. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157 [TBL] [Abstract][Full Text] [Related]
18. Analysis of polymorphic contamination in meloxicam raw materials and its effects on the physicochemical quality of drug product. Jacon Freitas JT; Santos Viana OMM; Bonfilio R; Doriguetto AC; de Araújo MB Eur J Pharm Sci; 2017 Nov; 109():347-358. PubMed ID: 28844846 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin. Lu Y; Zhang T; Tao J; Ji G; Wang S Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204 [TBL] [Abstract][Full Text] [Related]
20. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability. Zhang X; Zhang T; Lan Y; Wu B; Shi Z AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]